1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Advanced Ablation Catheters Overview
3 Products under Development
3.1 Advanced Ablation Catheters - Pipeline Products by Stage of Development
3.2 Advanced Ablation Catheters - Pipeline Products by Segment
3.3 Advanced Ablation Catheters - Pipeline Products by Territory
3.4 Advanced Ablation Catheters - Pipeline Products by Regulatory Path
3.5 Advanced Ablation Catheters - Pipeline Products by Estimated Approval Date
3.6 Advanced Ablation Catheters - Ongoing Clinical Trials
4 Advanced Ablation Catheters - Pipeline Products under Development by Companies
4.1 Advanced Ablation Catheters Companies - Pipeline Products by Stage of Development
4.2 Advanced Ablation Catheters - Pipeline Products by Stage of Development
5 Advanced Ablation Catheters Companies and Product Overview
5.1 Apama Medical Inc Company Overview
5.1.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Biosense Webster Inc Company Overview
5.2.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corp Company Overview
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 CardioFocus Inc Company Overview
5.4.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 CathRx Ltd Company Overview
5.5.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Cibiem, Inc. Company Overview
5.6.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 CryoTherapeutics SA Company Overview
5.7.1 CryoTherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
5.8 Ethicon US LLC Company Overview
5.8.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Farapulse Inc Company Overview
5.9.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Japan Lifeline Co Ltd Company Overview
5.10.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Medlumics SL Company Overview
5.11.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview
5.12 MicroPort Scientific Corp Company Overview
5.12.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 Shanghai HeartCare Medical Technology Co Ltd Company Overview
5.13.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 St. Jude Medical LLC Company Overview
5.14.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Stereotaxis Inc Company Overview
5.15.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Vanderbilt University Company Overview
5.16.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
6 Advanced Ablation Catheters- Recent Developments
6.1 Jun 13, 2024: Medtronic Confirms Global Layoffs
6.2 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team
6.3 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024
6.4 May 16, 2024: Biosense Webster to Present Data from 42 Company-Sponsored or Funded Studies, Including PFA and RF Innovation, at Heart Rhythm Society Annual Meeting
6.5 May 14, 2024: CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024
6.6 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
6.7 Apr 09, 2024: First Look at Data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH SF Platform for Atrial Fibrillation Presented at EHRA Congress
6.8 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
6.9 Mar 04, 2024: Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
6.10 Jan 08, 2024: Stereotaxis Announces First Patients Successfully Treated using MAGiC Ablation Catheter
6.11 Dec 14, 2023: Biosense Webster Begins Enrollment of SmartPulse Study in the U.S. to Evaluate RF and PFA Dual Energy Catheter to Treat Atrial Fibrillation
6.12 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
6.13 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
6.14 Aug 23, 2023: Boston Scientific Obtains Pre-Market Approval (PMA) for POLARx FIT Cryoablation Balloon Catheter
6.15 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer